4833M 15/850 (Actoplus met 850 mg / 15 mg)

Generic Name: metformin/pioglitazone

Pill imprint 4833M 15/850 has been identified as Actoplus met 850 mg / 15 mg.

ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 850 mg / 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 4833M 15/850

Actoplus met 850 mg / 15 mg 4833M 15/850 Front
Actoplus met 850 mg / 15 mg 4833M 15/850 Back
Actoplus met 850 mg / 15 mg 4833M 15/850
Actoplus met
Generic Name:
metformin/pioglitazone
Imprint:
4833M
15/850
Strength:
850 mg / 15 mg
Color:
White
Size:
18.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Takeda Pharmaceuticals America, Inc.
National Drug Code (NDC):
64764-0158
Inactive Ingredients:
povidone
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
hypromellose 2910 (6 mPa.s)
polyethylene glycol 8000
titanium dioxide
magnesium silicate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5553 Physicians Total Care Inc (repackager)
35356-0130 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)